The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.

scientific article

The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2006Sci...311.1474S
P356DOI10.1126/SCIENCE.1121176
P698PubMed publication ID16456039
P5875ResearchGate publication ID7318281

P50authorCatherine HankinsQ30513822
Joshua A SalomonQ37607615
Juan Pablo GutiérrezQ57318122
Stefano BertozziQ92658759
P2093author name stringNeff Walker
John Stover
Robert Greener
Peter D Ghys
Geoff P Garnett
J Ties Boerma
Eleanor Gouws
Paul De Lay
Karen A Stanecki
P433issue5766
P407language of work or nameEnglishQ1860
P921main subjectHIV/AIDSQ12199
preventionQ1717246
prevention of HIV/AIDSQ7242372
P304page(s)1474-1476
P577publication date2006-02-02
P1433published inScienceQ192864
P1476titleThe global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries
P478volume311

Reverse relations

cites work (P2860)
Q34470827A comparison of HIV detection rates using routine opt-out provider-initiated HIV testing and counseling versus a standard of care approach in a rural African setting
Q34919727A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortality
Q37798411AIDS in Asia amid competing priorities: a review of national responses to HIV
Q36557334AIDS: from crisis management to sustained strategic response
Q30394616Asia can afford universal access for AIDS prevention and treatment
Q35591286Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention
Q64055640Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting
Q30414374Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
Q46313407Can epidemiology inform global health and development targets?
Q30892349Can we spend our way out of the AIDS epidemic? A world halting AIDS model
Q36089732Changes in HIV risk behavior and seroincidence among clients presenting for repeat HIV counseling and testing in Moshi, Tanzania
Q36944602Changing cost of HIV interventions in the context of scaling-up in India
Q37456027Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania
Q58924950Coming to terms with complexity: a call to action for HIV prevention
Q36548078Containing HIV/AIDS in India: the unfinished agenda
Q33267835Cost-effectiveness of male circumcision for HIV prevention in a South African setting
Q35794458Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease
Q35729350Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice
Q33504903Determining a cost effective intervention response to HIV/AIDS in Peru
Q36941573Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
Q38114142Economic evaluations of point of care testing strategies for active tuberculosis
Q21144661Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review
Q34766899Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico
Q36941015Estimating the number of HIV infections averted: an approach and its issues
Q37063081Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe
Q41471847Estimating trends in life expectancy in HIV-positive individuals
Q37085142Global Fund-supported programmes contribution to international targets and the Millennium Development Goals: an initial analysis
Q30410700Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Q30892555HIV prevention cost-effectiveness: a systematic review
Q31118706HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
Q36958230Improving analysis of the size and dynamics of AIDS epidemics
Q39605470Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity.
Q33569197Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.
Q33952153Long-term costs and health impact of continued global fund support for antiretroviral therapy
Q33833876Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe
Q37203626Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis
Q28535033Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women
Q33299456Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings
Q46395904Routine testing for HIV/AIDS in sub-Saharan Africa: a philosopher's perspective
Q36661454S4HARA: System for HIV/AIDS resource allocation
Q37605568Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations
Q92661710The Big Four: Functional Assessment Research Informs Preventative Behavior Analysis
Q37428151The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan
Q34155879The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in India
Q35656683The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India
Q36821667The future of HIV prevention: control of sexually transmitted infections and circumcision interventions
Q33323442The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling
Q28484308The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study
Q22241890The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
Q49100701The welfare costs of HIV/AIDS in eastern Europe: an empirical assessment using the economic value-of-life approach
Q37182088Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?
Q33336557Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa
Q91913016What is global health? Key concepts and clarification of misperceptions: Report of the 2019 GHRP editorial meeting
Q26826936World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients

Search more.